We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+6.92%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$31.1B
AUM Growth
+$1.68B
Cap. Flow
+$21M
Cap. Flow %
0.07%
Top 10 Hldgs %
14.12%
Holding
3,080
New
66
Increased
2,426
Reduced
529
Closed
46

Top Buys

Rank Stock Value
1
CB icon
Chubb
CB
+$39M
2
HPE icon
Hewlett Packard
HPE
+$35.3M
3
SYF icon
Synchrony
SYF
+$29.5M
4
CMCSA icon
Comcast
CMCSA
+$25.4M
5
ILMN icon
Illumina
ILMN
+$13.5M

Top Sells

Rank Stock Value
1
CB
CHUBB CORPORATION
CB
+$43M
2
HPQ icon
HP
HPQ
+$38.8M
3
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
+$25.8M
4
SIAL
SIGMA - ALDRICH CORP
SIAL
+$22.9M
5
ALTR
Altera Corp
ALTR
+$21.5M

Sector Composition

Rank Sector Weight
1 Financials 15.31%
2 Healthcare 14.62%
3 Technology 14.1%
4 Industrials 10.66%
5 Consumer Discretionary 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOMX
2826
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$184K ﹤0.01%
22,719
+3,250
+17% +$24.3K
GNRT
2827
DELISTED
Gener8 Maritime, Inc.
GNRT
$184K ﹤0.01%
+19,505
New +$201K
ARC
2828
DELISTED
ARC Document Solutions, Inc.
ARC
$184K ﹤0.01%
41,516
+3,670
+10% +$19.6K
EMKR
2829
DELISTED
Emcore Corp
EMKR
$184K ﹤0.01%
3,004
-238
-7% -$16.5K
MCHX icon
2830
Marchex
MCHX
$82.4M
$183K ﹤0.01%
47,098
+1,610
+4% +$6.69K
ATRS
2831
DELISTED
Antares Pharma, Inc.
ATRS
$182K ﹤0.01%
150,355
+14,005
+10% +$19.5K
NVIV
2832
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$182K ﹤0.01%
1
– –
ORN icon
2833
Orion Group Holdings
ORN
$438M
$181K ﹤0.01%
43,369
+1,400
+3% +$6.08K
DGICA icon
2834
Donegal Group Class A
DGICA
$724M
$177K ﹤0.01%
12,563
+400
+3% +$5.6K
ANTH
2835
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$177K ﹤0.01%
4,769
+457
+11% +$20.2K
ADVM
2836
DELISTED
Adverum Biotechnologies
ADVM
$176K ﹤0.01%
1,844
+88
+5% +$7.73K
AMRC icon
2837
Ameresco
AMRC
$1.42B
$176K ﹤0.01%
28,164
+1,000
+4% +$6.45K
VOXX
2838
DELISTED
VOXX International Corporation Class A
VOXX
$176K ﹤0.01%
33,504
+1,330
+4% +$7.78K
HIL
2839
DELISTED
Hill International, Inc. Common Stock
HIL
$176K ﹤0.01%
45,253
+2,140
+5% +$7.47K
PETX
2840
DELISTED
Aratana Therapeutics, Inc.
PETX
$176K ﹤0.01%
31,564
+4,515
+17% +$29.8K
JMBA
2841
DELISTED
Jamba, Inc.
JMBA
$176K ﹤0.01%
13,025
+570
+5% +$7.81K
LCTX icon
2842
Lineage Cell Therapeutics
LCTX
$279M
$175K ﹤0.01%
52,857
+6,095
+13% +$18.2K
NRC icon
2843
NRC Health Common Stock
NRC
$434M
$175K ﹤0.01%
10,918
+850
+8% +$12.9K
CCO icon
2844
Clear Channel Outdoor Holdings
CCO
$1.23B
$174K ﹤0.01%
31,062
+2,661
+9% +$16.4K
EQNR icon
2845
Equinor
EQNR
$91.5B
$174K ﹤0.01%
12,454
+279
+2% +$4.35K
KVHI icon
2846
KVH Industries
KVHI
$188M
$173K ﹤0.01%
18,407
+1,460
+9% +$14.1K
CARB
2847
DELISTED
Carbonite Inc
CARB
$173K ﹤0.01%
17,636
+1,570
+10% +$16K
IHC
2848
DELISTED
Independence Holding Company
IHC
$173K ﹤0.01%
12,521
+336
+3% +$4.75K
LMNR icon
2849
Limoneira
LMNR
$246M
$172K ﹤0.01%
11,483
+1,015
+10% +$16.4K
DRNA
2850
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$172K ﹤0.01%
14,463
+1,355
+10% +$15.5K
112 113
114
115 116

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q4 2015 Portfolio in Review

As of Q4 2015, RhumbLine Advisers held 3,080 positions worth $31.1B, up 5.7% from $29.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q4 2015: portfolio turnover was 3.6%. RhumbLine Advisers opened 66 new positions and exited 46, leaving the 3,080-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

  • RhumbLine Advisers's largest Q4 2015 buy was Hewlett Packard: 4,220,807 shares worth $37.3M.
  • RhumbLine Advisers added most to Chubb in Q4 2015, an estimated $39M increase.
  • RhumbLine Advisers's biggest Q4 2015 reduction was HP, cutting an estimated $38.8M.
  • RhumbLine Advisers fully exited CHUBB CORPORATION in Q4 2015, selling an estimated $43M.
  • RhumbLine Advisers's ten largest holdings make up 14% of its $31.1B portfolio in Q4 2015.
  • RhumbLine Advisers opened 66 new positions and closed 46 in Q4 2015.
  • RhumbLine Advisers's portfolio value rose 5.7% quarter-over-quarter to $31.1B.

Based on RhumbLine Advisers's 13F filing for Q4 2015, filed 3 Feb 2016.